Jackson Hole Seminars Archives

Haemocomponents for Non Transfusional Use: Biological Aspects and New Urological Clinical Applications

Posted by Pierluigi Bove, MD | Jun 2018

Pierluigi Bove, MD, discusses the urological applications of haemocomponents, specifically using fibrin glue in the management of hemorrhagic cystitis. He explains the possibility of managing chronic cystitis, bladder pain syndrome, and chronic pelvic pain with platelet-rich plasma (PRP). Furthermore, he describes his upcoming project to test the effects of hyaluronic acid and PRP on the human epithelium.

Technology and its Impact on Patient Care

Posted by Peter G. Schulam, MD, PhD | Jun 2018

Peter Schulam, MD, PhD, argues that adopting robotic assisted surgery into urological practices can reduce medical errors and surgeon performance variability. Furthermore, he explains the need for larger and more structured medical data sets. This will enable machine learning when developing artificial intelligence (AI) to enhance prognostic and diagnostic accuracy, cancer mortality prediction, and interpretation of digitized images.

2017 AUA Guidelines for the Treatment of Stress Urinary Incontinence

Posted by Larissa V. Rodriguez, MD | Jun 2018

Larissa V. Rodriguez, MD, summarizes the 2017 American Urological Association (AUA) Stress Urinary Incontinence (SUI) guidelines and critiques their limitations. In particular, she criticizes the fact that their index patient does not represent patients urologists usually see, their exclusion of non-FDA approved interventions, and their insufficient emphasis on urodynamics.

AUA/ASTRO/SUO Guidelines on Clinically Localized Prostate Cancer

Posted by Riccardo Autorino, MD, PhD, FEBU | Jun 2018

Riccardo Autorino, MD, PhD, FEBU, summarizes the American Urological Association (AUA), the American Society for Radiation Oncology (ASTRO), and the Society of Urologic Oncology (SUO) guidelines on clinically localized prostate cancer. Specifically, he highlights recommendations on shared decision making, risk stratification to dictate the therapy, care options, active surveillance, and directions for future research.

Supra-Physiologic Testosterone Supplementation: Do Body Builders Know Something We Don’t?

Posted by Tobias S. Köhler, MD, MPH | Jun 2018

Tobias S. Kohler, MD, MPH, discusses the epidemiology and associated dangers of steroid abuse. Specifically, he explains steroid-related risk of testicular atrophy, gynecomastia, infertility, and sudden cardiac death. Through an anecdote, he illustrates the psychological and sociological causes of steroid abuse.